Clinical trial
Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic
NCT01222598 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- March 31, 2011
- Enrollment
- 588 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.